Central African Republic vs Syrian Arab Republic: Hypertension among adults aged 30-79 years, prevalence
Central African Republic
41.3
in 2019
Syrian Arab Republic
41.1
in 2019
Central African Republic rank
63rd
Syrian Arab Republic rank
64th
Hypertension among adults aged 30-79 years, prevalence over time
- Central African Republic
- Syrian Arab Republic
How they compare
Central African Republic currently reports 41.3 against 41.1 in Syrian Arab Republic, a difference of 0.2.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Syrian Arab Republic ahead.
Central African Republic ranks 63rd and Syrian Arab Republic ranks 64th of 193 countries.
Syrian Arab Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 39.95 | 42.47 | 2.52 | Syrian Arab Republic |
| 2000s | 41.37 | 43.65 | 2.28 | Syrian Arab Republic |
| 2010s | 41.74 | 42.19 | 0.45 | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension among adults aged 30-79 years, prevalence, Central African Republic or Syrian Arab Republic?
- Central African Republic, at 41.3 against 41.1 in Syrian Arab Republic as of 2019.
- What is the difference in hypertension among adults aged 30-79 years, prevalence between Central African Republic and Syrian Arab Republic?
- 0.2, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Syrian Arab Republic?
- 30 years are reported by both, from 1990 to 2019.
- How do Central African Republic and Syrian Arab Republic rank globally for hypertension among adults aged 30-79 years, prevalence?
- Central African Republic ranks 63rd and Syrian Arab Republic ranks 64th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension among adults aged 30-79 years, prevalence, age-standardized. Statizoid refreshes it automatically from the source and publishes the full history for both places.